Hussein Tawbi, MD, PhD
Department of Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Hussein Tawbi, MD, PhD: consultant/advisor/speaker: Bristol Myers Squibb, Boxer Capital, Eisai, Genentech, Ivoance, Jazz, Karyopharm, Medicenna, Merck, Novartis; researcher: Bristol Myers Squibb, Dragonfly Therapeutics, Eisai, EMD Serono, Genentech, GlaxoSmithKline, Merck, Novartis, RAPT Therapeutics.
Allison Betof Warner, MD, PhD
Assistant Professor of Medicine (Oncology)
Director, Melanoma Medical Oncology Program
Director, Solid Tumor Cellular Therapy
Leader, Melanoma & Cutaneous Oncology Clinical Research Group
Stanford University School of Medicine
Allison Betof Warner, MD, PhD: consultant/advisor/speaker: Bristol-Myers Squibb, Immatics, Instil Bio, Iovance, Lyell Immunopharma, Novartis, Pfizer; researcher: Iovance.
Adil Daud, MD
Clinical Professor of Medicine
Department of Medicine, Division of Hematology/Oncology
University of California
Professor of Medicine, Melanoma Oncology
San Francisco, California
Adil Daud, MBBS, has no relevant financial relationships to disclose.
Evan J. Lipson, MD
Associate Professor of Oncology
Melanoma and Cancer Immunology Programs
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Sidney Kimmel Comprehensive Cancer Center
Evan Lipson, MD: consultant/advisor/speaker: Bristol-Myers Squibb, CareDx, Eisai, Genentech, Immunocore, InstillBio; researcher: Bristol-Myers Squibb, Merck, Sanofi/Regeneron.
Ahmad Tarhini, MD, PhD
Department of Oncologic Services
University of South Florida Morsani College of Medicine
Departments of Cutaneous Oncology & Immunology
H. Lee Moffitt Cancer Center and Research Institute
Ahmad Tarhini, MD, PhD: consultant/advisor/speaker: AstraZeneca, Bristol-Myers Squibb, Instil Bio, Merck; researcher: Clinigen, Genentech/Roche, Nektar, Regeneron, Sanofi/Genzyme.